Literature DB >> 22488577

SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3.

Daniel Nowak1, Marion Klaumuenzer, Benjamin Hanfstein, Maximilian Mossner, Florian Nolte, Verena Nowak, Julia Oblaender, Anna Hecht, Gero Hütter, Seishi Ogawa, Alexander Kohlmann, Claudia Haferlach, Brigitte Schlegelberger, Jan Braess, Wolfgang Seifarth, Alice Fabarius, Philipp Erben, Susanne Saussele, Martin C Müller, Andreas Reiter, Thomas Buechner, Christel Weiss, Wolf-Karsten Hofmann, Eva Lengfelder.   

Abstract

To search for new copy number alterations (CNAs) in acute promyelocytic leukemia (APL), we analyzed DNA from leukemic blasts of 93 acute promyelocytic leukemia (APL) patients with Genome-Wide SNP 6.0 arrays (SNP-A). We identified 259 CNAs consisting of 170 heterozygous deletions, 82 amplifications, and 7 regions of copy number neutral loss of heterozygosity. One of the most common CNAs was a deletion on chromosomal subband 1q31.3 in 13 of 93 (14%) patients encompassing the coding regions for the microRNAs mir181a1/b1. In multivariable analysis with the covariates age, white blood cell count, platelet count, and FLT3-ITD/FLT3 D835 mutations we found that after adjustment for patients' age (P<0.0001), patients with 2 or more CNAs detected by SNP-A had a higher risk of death (hazard ratio=5.942, P=0.0015) than patients with 0 or 1 CNA. Deletions of 1q31.3 were associated with a higher number of CNAs (median 2 vs. 8, P<0.0001) and were a strong independent prognostic factor for an increased risk of relapse (hazard ratio=28.9, P=0.0031). This study presents a comprehensive assessment of new CNAs as pathomechanistically relevant targets and possible prognostic factors which could refine risk stratification of APL.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488577     DOI: 10.1002/gcc.21961

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

1.  Different loss of material in recurrent chromosome 20 interstitial deletions in Shwachman-Diamond syndrome and in myeloid neoplasms.

Authors:  Roberto Valli; Barbara Pressato; Cristina Marletta; Lydia Mare; Giuseppe Montalbano; Francesco Lo Curto; Francesco Pasquali; Emanuela Maserati
Journal:  Mol Cytogenet       Date:  2013-12-12       Impact factor: 2.009

2.  Single-nucleotide polymorphism array-based karyotyping of acute promyelocytic leukemia.

Authors:  Inés Gómez-Seguí; Dolors Sánchez-Izquierdo; Eva Barragán; Esperanza Such; Irene Luna; María López-Pavía; Mariam Ibáñez; Eva Villamón; Carmen Alonso; Iván Martín; Marta Llop; Sandra Dolz; Oscar Fuster; Pau Montesinos; Carolina Cañigral; Blanca Boluda; Claudia Salazar; Jose Cervera; Miguel A Sanz
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

3.  Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML.

Authors:  D L Stirewalt; E L Pogosova-Agadjanyan; K Tsuchiya; J Joaquin; S Meshinchi
Journal:  Blood Cancer J       Date:  2014-05-02       Impact factor: 11.037

4.  Immunophenotypes and immune markers associated with acute promyelocytic leukemia prognosis.

Authors:  Fang Xu; Chang-Xin Yin; Chun-Li Wang; Xue-Jie Jiang; Ling Jiang; Zhi-Xiang Wang; Zheng-Shan Yi; Kai-Kai Huang; Fan-Yi Meng
Journal:  Dis Markers       Date:  2014-06-19       Impact factor: 3.434

5.  Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.

Authors:  Wei-Yu Lin; Sarah E Fordham; Eric Hungate; Nicola J Sunter; Claire Elstob; Yaobo Xu; Catherine Park; Anne Quante; Konstantin Strauch; Christian Gieger; Andrew Skol; Thahira Rahman; Lara Sucheston-Campbell; Junke Wang; Theresa Hahn; Alyssa I Clay-Gilmour; Gail L Jones; Helen J Marr; Graham H Jackson; Tobias Menne; Mathew Collin; Adam Ivey; Robert K Hills; Alan K Burnett; Nigel H Russell; Jude Fitzgibbon; Richard A Larson; Michelle M Le Beau; Wendy Stock; Olaf Heidenreich; Abrar Alharbi; David J Allsup; Richard S Houlston; Jean Norden; Anne M Dickinson; Elisabeth Douglas; Clare Lendrem; Ann K Daly; Louise Palm; Kim Piechocki; Sally Jeffries; Martin Bornhäuser; Christoph Röllig; Heidi Altmann; Leo Ruhnke; Desiree Kunadt; Lisa Wagenführ; Heather J Cordell; Rebecca Darlay; Mette K Andersen; Maria C Fontana; Giovanni Martinelli; Giovanni Marconi; Miguel A Sanz; José Cervera; Inés Gómez-Seguí; Thomas Cluzeau; Chimène Moreilhon; Sophie Raynaud; Heinz Sill; Maria Teresa Voso; Francesco Lo-Coco; Hervé Dombret; Meyling Cheok; Claude Preudhomme; Rosemary E Gale; David Linch; Julia Gaal-Wesinger; Andras Masszi; Daniel Nowak; Wolf-Karsten Hofmann; Amanda Gilkes; Kimmo Porkka; Jelena D Milosevic Feenstra; Robert Kralovics; David Grimwade; Manja Meggendorfer; Torsten Haferlach; Szilvia Krizsán; Csaba Bödör; Friedrich Stölzel; Kenan Onel; James M Allan
Journal:  Nat Commun       Date:  2021-10-29       Impact factor: 14.919

6.  MicroRNAs in Myeloid Hematological Malignancies.

Authors:  Maria Ciccone; George Adrian Calin
Journal:  Curr Genomics       Date:  2015-10       Impact factor: 2.236

Review 7.  Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene.

Authors:  Alessandro Liquori; Mariam Ibañez; Claudia Sargas; Miguel Ángel Sanz; Eva Barragán; José Cervera
Journal:  Cancers (Basel)       Date:  2020-03-08       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.